Approval · Notice of Compliance 36094 · 2025
TUKYSA: Notice of Compliance 36094
Issued October 1, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36094
- Date
- October 1, 2025
- Company
- Seagen Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the controls (in-process tests and/or acceptance criteria) applied during the manufacturing process or on intermediates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TUKYSA | Not yet assigned | — |